Chapter 4: Marijuana Myths and Other Important Concepts About Weed

BACK . Book Description

Marijuana is Not Addictive; Marijuana is natural so it can’t be bad; Weed is not a gateway drug to harder drugs; There is not enough scientific study of marijuana.; Legalization and the public perception of safety; Industry Disinformation; Weed Use Trajectories; Edibles; Poly-Substance Use; Thoughts about Medical Marijuana

Click on the link, PMID, or PMCID to go directly to the page, abstract or scientific paper. Use your browser FIND function (Ctrl F) to search for keywords.

Refs. 43-121

43. Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3(8):760-73. PubMed PMID: 27475769; PubMed Central PMCID: 6135092. FREE

44. Compton WM, Han B, Jones CM, Blanco C. Cannabis use disorders among adults in the United States during a time of increasing use of cannabis. Drug Alcohol Depend. 2019;204:107468. PubMed PMID: 31586809.

45. Yuan M, Kanellopoulos T, Kotbi N. Cannabis use and psychiatric illness in the context of medical marijuana legalization: A clinical perspective. Gen Hosp Psychiatry. 2019;61:82-3. PubMed PMID: 31488324.

46. Hill KP. Marijuana: The Unbiased Truth About The Worlds Most Popular Weed.: Hazelden; 2015. 206 p.

47. Cerda M, Mauro C, Hamilton A, Levy NS, Santaella-Tenorio J, Hasin D, et al. Association Between Recreational Marijuana Legalization in the United States and Changes in Marijuana Use and Cannabis Use Disorder From 2008 to 2016. JAMA Psychiatry. 2019. PubMed PMID: 31722000; PubMed Central PMCID: 6865220. FREE

48.Lope z-Quintero C, Perez de los Cobos J, Hasin DS, Okuda M, Wang S, Grant BF, et al. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 2011;115(1-2):120-30. PubMed PMID: 21145178; PubMed Central PMCID: 3069146. FREE

49. Ferland JN, Hurd YL. Deconstructing the neurobiology of cannabis use disorder. Nat Neurosci. 2020. PubMed PMID: 32251385.

50. Chandra S, Radwan MM, Majumdar CG, Church JC, Freeman TP, ElSohly MA. New trends in cannabis potency in USA and Europe during the last decade (2008-2017). Eur Arch Psychiatry Clin Neurosci. 2019;269(1):5-15. PubMed PMID: 30671616.

51. Bahji A, Stephenson C, Tyo R, Hawken ER, Seitz DP. Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3(4):e202370. PubMed PMID: 32271390. PubMed Central PMCID: 7146100 FREE

52. .American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.)

53. Gaston TE, Mendrick DL, Paine MF, Roe AL, Yeung CK. “Natural” is not synonymous with “Safe”: Toxicity of Natural Products Alone and in combination with pharmaceutical agents. Regul Toxicol Pharmacol. 2020:104642. PubMed PMID: 32197968.

54. Oleander. Available from:

55. Wolfsbane. Available from:

56. Craven CB, Wawryk N, Jiang P, Liu Z, Li XF. Pesticides and trace elements in cannabis: Analytical and environmental challenges and opportunities. J Environ Sci (China). 2019;85:82-93. PubMed PMID: 31471034.

57. Atapattu SN, Johnson KRD. Pesticide analysis in cannabis products. J Chromatogr A. 2020;1612:460656. PubMed PMID: 31679712.

58. Maguire WJ, Call CW, Cerbu C, Jambor KL, Benavides-Montes VE. Comprehensive Determination of Unregulated Pesticide Residues in Oregon Cannabis Flower by Liquid Chromatography Paired with Triple Quadrupole Mass Spectrometry and Gas Chromatography Paired with Triple Quadrupole Mass Spectrometry. J Agric Food Chem. 2019;67(46):12670-4. PubMed PMID: 31398037.

59. Evoy R, Kincl L. Evaluation of Pesticides Found in Oregon Cannabis from 2016 to 2017. Ann Work Expo Health. 2019. PubMed PMID: 31621879.

60. Fergusson DM, Boden JM, Horwood LJ. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction. 2006;101(4):556-69. PubMed PMID: 16548935.

61.Secades-Villa R, Garcia-Rodriguez O, Jin CJ, Wang S, Blanco C. Probability and predictors of the cannabis gateway effect: a national study. Int J Drug Policy. 2015;26(2):135-42. PubMed PMID: 25168081; PubMed Central PMCID: 4291295. FREE

62. Rabiee R, Lundin A, Agardh E, Forsell Y, Allebeck P, Danielsson AK. Cannabis use, subsequent other illicit drug use and drug use disorders: A 16-year follow-up study among Swedish adults. Addict Behav. 2020;106:106390. PubMed PMID: 32179379. FREE

63. Degenhardt L, Hall W, Lynskey M. The relationship between cannabis use and other substance use in the general population. Drug Alcohol Depend. 2001;64(3):319-27. PubMed PMID: 11672946.

64. Kandel D. Stages in adolescent involvement in drug use. Science. 1975;190(4217):912-4. PubMed PMID: 1188374.

65. Cappelli C, Ames SL, Xie B, Pike JR, Stacy AW. Acceptance of Drug Use Mediates Future Hard Drug Use Among At-Risk Adolescent Marijuana, Tobacco, and Alcohol Users. Prev Sci. 2020. PubMed PMID: 32929694.

66. Panlilio LV, Zanettini C, Barnes C, Solinas M, Goldberg SR. Prior exposure to THC increases the addictive effects of nicotine in rats. Neuropsychopharmacology. 2013;38(7):1198-208. PubMed PMID: 23314220; PubMed Central PMCID: 3656362. FREE

67. Lecca D, Scifo A, Pisanu A, Valentini V, Piras G, Sil A, et al. Adolescent cannabis exposure increases heroin reinforcement in rats genetically vulnerable to addiction. Neuropharmacology. 2020;166:107974. PubMed PMID: 32007624.

68. Ishida JH, Zhang AJ, Steigerwald S, Cohen BE, Vali M, Keyhani S. Sources of Information and Beliefs About the Health Effects of Marijuana. J Gen Intern Med. 2020;35(1):153-9. PubMed PMID: 31637640; PubMed Central PMCID: 6957653. FREE

69. Wen H, Hockenberry JM, Druss BG. The Effect of Medical Marijuana Laws on Marijuana-Related Attitude and Perception Among US Adolescents and Young Adults. Prev Sci. 2019;20(2):215-23. PubMed PMID: 29767282.

70. Allen JA, Farrelly MC, Duke JC, Kamyab K, Nonnemaker JM, Wylie S, et al. Perceptions of the relative harmfulness of marijuana and alcohol among adults in Oregon. Prev Med. 2018;109:34-8. PubMed PMID: 29330028.

71. Chadi N, Levy S, Weitzman ER. Moving beyond perceived riskiness: Marijuana-related beliefs and marijuana use in adolescents. Subst Abus. 2019:1-4. PubMed PMID: 31361591.

72. Union of Concerned Scientists- Disinformation Playbook [6-22-20]. Available from:

73. Humphreys K, Hall WD. Reducing the risks of distortion in cannabis research. Addiction. 2020;115(5):799-801. PubMed PMID: 31491039.

74. Windle M, Wiesner M. Trajectories of marijuana use from adolescence to young adulthood: predictors and outcomes. Dev Psychopathol. 2004;16(4):1007-27. PubMed PMID: 15704825.

75. Brook JS, Lee JY, Brown EN, Finch SJ, Brook DW. Developmental trajectories of marijuana use from adolescence to adulthood: personality and social role outcomes. Psychol Rep. 2011;108(2):339-. PubMed PMID: 21675549; PubMed Central PMCID: 3117277. FREE

76. Terry-McElrath YM, O’Malley PM, Johnston LD, Bray BC, Patrick ME, Schulenberg JE. Longitudinal patterns of marijuana use across ages 18-50 in a US national sample: A descriptive examination of predictors and health correlates of repeated measures latent class membership. Drug Alcohol Depend. 2017;171:70-83. PubMed PMID: 28024188; PubMed Central PMCID: 5263048. FREE

77. De Genna NM, Cornelius MD, Goldschmidt L, Day NL. Maternal age and trajectories of cannabis use. Drug Alcohol Depend. 2015;156:199-206. PubMed PMID: 26429727; PubMed Central PMCID: 4633363. FREE

78. Thompson K, Leadbeater B, Ames M, Merrin GJ. Associations Between Marijuana Use Trajectories and Educational and Occupational Success in Young Adulthood. Prev Sci. 2019;20(2):257-69. PubMed PMID: 29704147; PubMed Central PMCID: 6414467. FREE

79. Passarotti AM, Crane NA, Hedeker D, Mermelstein RJ. Longitudinal trajectories of marijuana use from adolescence to young adulthood. Addict Behav. 2015;45:301-8. PubMed PMID: 25792233; PubMed Central PMCID: 4374005. FREE

80. Suerken CK, Reboussin BA, Egan KL, Sutfin EL, Wagoner KG, Spangler J, et al. Marijuana use trajectories and academic outcomes among college students. Drug Alcohol Depend. 2016;162:137-45. PubMed PMID: 27020322; PubMed Central PMCID: 4835174. FREE

81. Arria AM, Caldeira KM, Bugbee BA, Vincent KB, O’Grady KE. The academic consequences of marijuana use during college. Psychol Addict Behav. 2015;29(3):564-75. PubMed PMID: 26237288; PubMed Central PMCID: 4586361. FREE

82. Marmet S, Studer J, Wicki M, Gmel G. Cannabis use disorder trajectories and their prospective predictors in a large population-based sample of young Swiss men. Addiction. 2020. PubMed PMID: 32621560.

83. Hancock-Allen JB, Barker L, VanDyke M, Holmes DB. Notes from the Field: Death Following Ingestion of an Edible Marijuana Product–Colorado, March 2014. MMWR Morb Mortal Wkly Rep. 2015;64(28):771-2. PubMed PMID: 26203632; PubMed Central PMCID: 4584864. FREE

84. Zipursky JS, Bogler OD, Stall NM. Edible cannabis. CMAJ. 2020;192(7):E162. PubMed PMID: 32071107.

85. Zuckermann AME, Williams GC, Battista K, Jiang Y, de Groh M, Leatherdale ST. Prevalence and correlates of youth poly-substance use in the COMPASS study. Addict Behav. 2020;107:106400. PubMed PMID: 32222564.

86. Cairns KE, Yap MB, Pilkington PD, Jorm AF. Risk and protective factors for depression that adolescents can modify: a systematic review and meta-analysis of longitudinal studies. J Affect Disord. 2014;169:61-75. PubMed PMID: 25154536.

87. Kelly AB, Chan GC, Mason WA, Williams JW. The relationship between psychological distress and adolescent polydrug use. Psychol Addict Behav. 2015;29(3):787-93. PubMed PMID: 26415064.

88. Lopez-Quintero C, Granja K, Hawes S, Duperrouzel JC, Pacheco-Colon I, Gonzalez R. Transition to drug co-use among adolescent cannabis users: The role of decision-making and mental health. Addict Behav. 2018;85:43-50. PubMed PMID: 29843040; PubMed Central PMCID: 6740328. FREE

89. Bohnert KM, Walton MA, Resko S, Barry KT, Chermack ST, Zucker RA, et al. Latent class analysis of substance use among adolescents presenting to urban primary care clinics. Am J Drug Alcohol Abuse. 2014;40(1):44-50. PubMed PMID: 24219231; PubMed Central PMCID: 4346305. FREE

90. Maslowsky J, Schulenberg JE, O’Malley PM, Kloska DD. Depressive symptoms, conduct problems, and risk for polysubstance use among adolescents: Results from US national surveys. Ment Health Subst Use. 2013;7(2):157-69. PubMed PMID: 24578719; PubMed Central PMCID: 3932991. FREE

91. Chadi N, Li G, Cerda N, Weitzman ER. Depressive Symptoms and Suicidality in Adolescents Using e-Cigarettes and Marijuana: A Secondary Data Analysis From the Youth Risk Behavior Survey. J Addict Med. 2019;13(5):362-5. PubMed PMID: 30688723.

92. Werner AK, Koumans EH, Chatham-Stephens K, Salvatore PP, Armatas C, Byers P, et al. Hospitalizations and Deaths Associated with EVALI. N Engl J Med. 2020;382(17):1589-98. PubMed PMID: 32320569.

93. Vaping EVALI CDC [4-24-20]. Available from:

94. Kowitt SD, Osman A, Meernik C, Zarkin GA, Ranney LM, Martin J, et al. Vaping cannabis among adolescents: prevalence and associations with tobacco use from a cross-sectional study in the USA. BMJ Open. 2019;9(6):e028535. PubMed PMID: 31196904; PubMed Central PMCID: 6585821. FREE

95. Noorbakhsh S, Afzali MH, Boers E, Conrod PJ. Cognitive Function Impairments Linked to Alcohol and Cannabis Use During Adolescence: A Study of Gender Differences. Front Hum Neurosci. 2020;14:95. PubMed PMID: 32317950; PubMed Central PMCID: 7154290. FREE

96. Wade NE, Thomas AM, Gruber SA, Tapert SF, Filbey FM, Lisdahl KM. Binge and Cannabis Co-Use Episodes in Relation to White Matter Integrity in Emerging Adults. Cannabis Cannabinoid Res. 2020;5(1):62-72. PubMed PMID: 32322677; PubMed Central PMCID: 7173670. FREE

97. Ramaekers JG. Driving Under the Influence of Cannabis: An Increasing Public Health Concern. JAMA. 2018;319(14):1433-4. PubMed PMID: 29582068.

98. Sayer G, Ialomiteanu A, Stoduto G, Wickens CM, Mann RE, Le Foll B, et al. Increased collision risk among drivers who report driving after using alcohol and after using cannabis. Can J Public Health. 2014;105(1):e92-3. PubMed PMID: 24735704; PubMed Central PMCID: 6972259. FREE

99. Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA. 2015;313(24):2456-73. PubMed PMID: 26103030.

100. Kesner AJ, Lovinger DM. Cannabinoids, Endocannabinoids and Sleep. Front Mol Neurosci. 2020;13:125. PubMed PMID: 32774241; PubMed Central PMCID: 7388834. FREE

101. Wilsey B, Marcotte T, Deutsch R, Gouaux B, Sakai S, Donaghe H. Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain. 2013;14(2):136-48. PubMed PMID: 23237736; PubMed Central PMCID: 3566631. FREE

102. Raymundi AM, da Silva TR, Sohn JMB, Bertoglio LJ, Stern CA. Effects of (9)-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies. BMC Psychiatry. 2020;20(1):420. PubMed PMID: 32842985.

103. Andreae MH, Carter GM, Shaparin N, Suslov K, Ellis RJ, Ware MA, et al. Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data. J Pain. 2015;16(12):1221-32. PubMed PMID: 26362106; PubMed Central PMCID: 4666747. FREE

104. Nielsen S, Germanos R, Weier M, Pollard J, Degenhardt L, Hall W, et al. The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews. Curr Neurol Neurosci Rep. 2018;18(2):8. PubMed PMID: 29442178.

105. Szejko N, Fremer C, Muller-Vahl KR. Cannabis Improves Obsessive-Compulsive Disorder-Case Report and Review of the Literature. Front Psychiatry. 2020;11:681. PubMed PMID: 32848902; PubMed Central PMCID: 7396551. FREE

106. Billnitzer A, Jankovic J. Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments. Neurotherapeutics. 2020. PubMed PMID: 32856174.

107. Dibba P, Li AA, Cholankeril G, Ali Khan M, Kim D, Ahmed A. Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary. Nutr Metab Insights. 2019;12 PubMed PMID: 31308686; PubMed Central PMCID: 6612909. FREE

108. Adejumo AC, Alliu S, Ajayi TO, Adejumo KL, Adegbala OM, Onyeakusi NE, et al. Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study. PLoS One. 2017;12(4):e0176416. PubMed PMID: 28441459; PubMed Central PMCID: 5404771. FREE

109.Adej umo AC, Adegbala OM, Adejumo KL, Bukong TN. Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis. Can J Gastroenterol Hepatol. 2018;2018:9430953. PubMed PMID: 30345261; PubMed Central PMCID: 6174743. FREE

110. Cuttler C, Spradlin A, Cleveland MJ, Craft RM. Short- and Long-Term Effects of Cannabis on Headache and Migraine. J Pain. 2019. PubMed PMID: 31715263.

111. Erridge S, Miller M, Gall T, Costanzo A, Pacchetti B, Sodergren MH. A Comprehensive Patient and Public Involvement Program Evaluating Perception of Cannabis-Derived Medicinal Products in the Treatment of Acute Postoperative Pain, Nausea, and Vomiting Using a Qualitative Thematic Framework. Cannabis Cannabinoid Res. 2020;5(1):73-80. PubMed PMID: 32322678; PubMed Central PMCID: 7173671. FREE

112. Adhiyaman V, Arshad S. Cannabis for intractable nausea after bilateral cerebellar stroke. J Am Geriatr Soc. 2014;62(6):1199. PubMed PMID: 24925562.

113. Smith LA, Azariah F, Lavender VT, Stoner NS, Bettiol S. Cannabinoids for nausea and vomiting in adults with cancer reeiving chemotherapy. Cochrane Database Syst Rev. 2015;(11):CD009464. PubMed PMID: 26561338; PubMed Central PMCID: 6931414. FREE

114. Shar key KA, Darmani NA, Parker LA. Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system. Eur J Pharmacol. 2014;722:134-46. PubMed PMID: 24184696; PubMed Central PMCID: 3883513. FREE

115. Black N, Stockings E, Campbell G, Tran LT, Zagic D, Hall WD, et al. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis. Lancet Psychiatry. 2019;6(12):995-1010. PubMedPMID: 31672337; PubMed Central PMCID: 6949116. FREE

116. Nugent SM, Morasco BJ, O’Neil ME, Freeman M, Low A, Kondo K, et al. The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General Harms: A Systematic Review. Ann Intern Med. 2017;167(5):319-31. Epub 2017/08/15. doi: 10.7326/M17-0155. PubMed PMID: 28806817. FREE

117. Pratt M., Stevens A.,Thuku M., Butler C., Skidmore B., Wieland L.S., Clemons M., Kanji M., Hutton B. Benefits and harms of medical cannabis: a scoping review of systematic reviews. Syst Rev. 2019 Dec 10;8(1):320. PubMed PMID31823819_PubMed Central PMC6905063 FREE

118. Dronabinol Wikipedia [8/29/2020]. Available from:

119. Savitex Wikipedia [9/10/2020]. Available from:

120. Nabilone-Wikipedia [8/29/2020]. Available from:

121. Epidiolex [9/12/2020]. Available from:

Click here for the book:

%d bloggers like this: